| HORIZON | TRADES | WIN RATE | INSIDER RETURN | SPY RETURN | MEAN EXCESS | MEDIAN EXCESS | T-STAT |
|---|---|---|---|---|---|---|---|
| 7d | 8 | +75.00% | -12.12% | -0.13% | -11.98% | -20.76% | — |
| 14d | 8 | +87.50% | -14.82% | -1.73% | -13.09% | -28.14% | — |
| 30d | 8 | +75.00% | -17.06% | +1.29% | -18.36% | -29.16% | — |
| 60d | 8 | +75.00% | -29.96% | +4.98% | -34.94% | -57.12% | — |
| 90d | 8 | +87.50% | -17.45% | +5.01% | -22.46% | -55.42% | — |
| 180d | 8 | +75.00% | -18.32% | +12.25% | -30.57% | -66.97% | — |
| 1y | 8(2 pending) | +83.33% | -52.96% | +14.56% | -67.52% | -86.41% | — |
| 2y | 8(3 pending) | +100.00% | -65.19% | +7.55% | -72.74% | -72.74% | — |
| COMPANY | TYPE | SHARES | PRICE | VALUE | HELD AFTER | TRADE DATE | FILED | DETAILS |
|---|---|---|---|---|---|---|---|---|
| MNPR MONOPAR THERAPEUTICS | SALE Chief Executive Officer | 4,084 | $92.59 | $378.1K | 99,267 | Jun 30, 2026 | Jul 2, 2026 ↗ | View → |
| MNPR MONOPAR THERAPEUTICS | SALE Chief Executive Officer | 12,873 | — | — | 93,403 | Jun 30, 2026 | Jul 2, 2026 ↗ | View → |
| MNPR MONOPAR THERAPEUTICS | PURCHASE Chief Executive Officer | 12,873 | — | — | 103,351 | Jun 30, 2026 | Jul 2, 2026 ↗ | View → |
| MNPR MONOPAR THERAPEUTICS | SALE Chief Executive Officer | 6,732 | — | — | 106,276 | Mar 31, 2026 | Apr 2, 2026 ↗ | View → |
| MNPR MONOPAR THERAPEUTICS | SALE Chief Executive Officer | 1,972 | $54.79 | $108.0K | 90,478 | Mar 31, 2026 | Apr 2, 2026 ↗ | View → |
| MNPR MONOPAR THERAPEUTICS | PURCHASE Chief Executive Officer | 6,732 | — | — | 92,450 | Mar 31, 2026 | Apr 2, 2026 ↗ | View → |
| MNPR MONOPAR THERAPEUTICS | PURCHASE Chief Executive Officer | 8,724 | — | — | 88,276 | Dec 31, 2025 | Jan 5, 2026 ↗ | View → |
| MNPR MONOPAR THERAPEUTICS | SALE Chief Executive Officer | 8,724 | — | — | 113,008 | Dec 31, 2025 | Jan 5, 2026 ↗ | View → |
| MNPR MONOPAR THERAPEUTICS | SALE Chief Executive Officer | 2,558 | $65.30 | $167.0K | 85,718 | Dec 31, 2025 | Jan 5, 2026 ↗ | View → |
| MNPR MONOPAR THERAPEUTICS | PURCHASEGRANT Stock grant | 16,753 | — | — | 16,753 | Dec 2, 2025 | Dec 8, 2025 ↗ | View → |
| MNPR MONOPAR THERAPEUTICS | PURCHASEGRANT Stock grant | 49,133 | — | — | 121,732 | Dec 2, 2025 | Dec 8, 2025 ↗ | View → |
| MNPR MONOPAR THERAPEUTICS | SALE Chief Executive Officer | 2,646 | $81.67 | $216.1K | 79,552 | Sep 30, 2025 | Oct 2, 2025 ↗ | View → |
| MNPR MONOPAR THERAPEUTICS | PURCHASE Chief Executive Officer | 8,726 | — | — | 82,198 | Sep 30, 2025 | Oct 2, 2025 ↗ | View → |
| MNPR MONOPAR THERAPEUTICS | SALE Chief Executive Officer | 8,726 | — | — | 72,599 | Sep 30, 2025 | Oct 2, 2025 ↗ | View → |
| MNPR MONOPAR THERAPEUTICS | SALE Chief Executive Officer | 550,229 | $63.61 | $35.00M | 272,026 | Sep 24, 2025 | Sep 26, 2025 ↗ | View → |
| MNPR MONOPAR THERAPEUTICS | SALE Chief Executive Officer | 16,800 | — | — | 0 | Jul 14, 2025 | Jul 16, 2025 ↗ | View → |
| MNPR MONOPAR THERAPEUTICS | SALE Chief Executive Officer | 16,800 | $40.00 | $672.0K | 73,472 | Jul 14, 2025 | Jul 16, 2025 ↗ | View → |
| MNPR MONOPAR THERAPEUTICS | PURCHASE Chief Executive Officer | 16,800 | $0.01 | $84 | 90,272 | Jul 14, 2025 | Jul 16, 2025 ↗ | View → |
| MNPR MONOPAR THERAPEUTICS | PURCHASE Chief Executive Officer | 13,344 | — | — | 79,337 | Jun 30, 2025 | Jul 2, 2025 ↗ | View → |
| MNPR MONOPAR THERAPEUTICS | SALE Chief Executive Officer | 13,344 | — | — | 81,325 | Jun 30, 2025 | Jul 2, 2025 ↗ | View → |
| MNPR MONOPAR THERAPEUTICS | SALE Chief Executive Officer | 5,865 | $35.78 | $209.8K | 73,472 | Jun 30, 2025 | Jul 2, 2025 ↗ | View → |
| MNPR MONOPAR THERAPEUTICS | SALE Chief Executive Officer | 33,334 | $35.00 | $1.17M | 822,255 | Apr 2, 2025 | Apr 4, 2025 ↗ | View → |
| MNPR MONOPAR THERAPEUTICS | PURCHASE Chief Executive Officer | 4,106 | — | — | 67,197 | Mar 31, 2025 | Apr 2, 2025 ↗ | View → |
| MNPR MONOPAR THERAPEUTICS | SALE Chief Executive Officer | 1,204 | $36.41 | $43.8K | 65,993 | Mar 31, 2025 | Apr 2, 2025 ↗ | View → |
| MNPR MONOPAR THERAPEUTICS | SALE Chief Executive Officer | 4,106 | — | — | 94,669 | Mar 31, 2025 | Apr 2, 2025 ↗ | View → |
| MNPR MONOPAR THERAPEUTICS | SALE Chief Executive Officer | 1,759 | $31.70 | $55.8K | 63,091 | Mar 4, 2025 | Mar 7, 2025 ↗ | View → |
| MNPR MONOPAR THERAPEUTICS | PURCHASEGRANT Stock grant | 79,899 | — | — | 104,777 | Mar 4, 2025 | Mar 7, 2025 ↗ | View → |
| MNPR MONOPAR THERAPEUTICS | SALE Chief Executive Officer | 6,002 | — | — | 98,775 | Mar 4, 2025 | Mar 7, 2025 ↗ | View → |
| MNPR MONOPAR THERAPEUTICS | PURCHASEGRANT Stock grant | 85,759 | — | — | 85,759 | Mar 4, 2025 | Mar 7, 2025 ↗ | View → |
| MNPR MONOPAR THERAPEUTICS | PURCHASE Chief Executive Officer | 6,002 | — | — | 64,850 | Mar 4, 2025 | Mar 7, 2025 ↗ | View → |
| MNPR MONOPAR THERAPEUTICS | PURCHASE Chief Executive Officer | 62,815 | — | — | 62,815 | Jan 28, 2025 | Jan 30, 2026 ↗ | View → |
| MNPR MONOPAR THERAPEUTICS | SALE Chief Executive Officer | 4,895 | — | — | 24,879 | Dec 31, 2024 | Jan 2, 2025 ↗ | View → |
| MNPR MONOPAR THERAPEUTICS | PURCHASE Chief Executive Officer | 4,895 | — | — | 61,057 | Dec 31, 2024 | Jan 2, 2025 ↗ | View → |
| MNPR MONOPAR THERAPEUTICS | SALE Chief Executive Officer | 2,209 | $22.00 | $48.6K | 58,848 | Dec 31, 2024 | Jan 2, 2025 ↗ | View → |
| MNPR MONOPAR THERAPEUTICS | SALE Chief Executive Officer | 1,918 | $6.74 | $12.9K | 56,162 | Sep 30, 2024 | Oct 2, 2024 ↗ | View → |
| MNPR MONOPAR THERAPEUTICS | SALE Chief Executive Officer | 4,895 | — | — | 29,774 | Sep 30, 2024 | Oct 2, 2024 ↗ | View → |
| MNPR MONOPAR THERAPEUTICS | PURCHASE Chief Executive Officer | 4,895 | — | — | 58,080 | Sep 30, 2024 | Oct 2, 2024 ↗ | View → |
| MNPR MONOPAR THERAPEUTICS | SALE Chief Executive Officer | 8,684 | $0.73 | $6.3K | 265,922.8 | Jun 30, 2024 | Jul 2, 2024 ↗ | View → |
| MNPR MONOPAR THERAPEUTICS | PURCHASE Chief Executive Officer | 24,476 | — | — | 274,606.8 | Jun 30, 2024 | Jul 2, 2024 ↗ | View → |
| MNPR MONOPAR THERAPEUTICS | SALE Chief Executive Officer | 24,476 | — | — | 173,335 | Jun 30, 2024 | Jul 2, 2024 ↗ | View → |
| MNPR MONOPAR THERAPEUTICS | SALE Chief Executive Officer | 84,000 | — | — | 0 | May 28, 2024 | May 30, 2024 ↗ | View → |
| MNPR MONOPAR THERAPEUTICS | PURCHASE Chief Executive Officer | 84,000 | $0.00 | $84 | 250,130.8 | May 28, 2024 | May 30, 2024 ↗ | View → |
| MNPR MONOPAR THERAPEUTICS | SALE Chief Executive Officer | 24,474 | — | — | 197,811 | Mar 31, 2024 | Apr 2, 2024 ↗ | View → |
| MNPR MONOPAR THERAPEUTICS | SALE Chief Executive Officer | 7,172 | $0.68 | $4.9K | 166,130.8 | Mar 31, 2024 | Apr 2, 2024 ↗ | View → |
| MNPR MONOPAR THERAPEUTICS | PURCHASE Chief Executive Officer | 24,474 | — | — | 173,302.8 | Mar 31, 2024 | Apr 2, 2024 ↗ | View → |
| MNPR MONOPAR THERAPEUTICS | SALE Chief Executive Officer | 2,327 | $0.34 | $792 | 148,828.8 | Jan 1, 2024 | Jan 3, 2024 ↗ | View → |
| MNPR MONOPAR THERAPEUTICS | SALE Chief Executive Officer | 6,724 | — | — | 222,285 | Jan 1, 2024 | Jan 3, 2024 ↗ | View → |
| MNPR MONOPAR THERAPEUTICS | PURCHASE Chief Executive Officer | 6,724 | — | — | 151,155.8 | Jan 1, 2024 | Jan 3, 2024 ↗ | View → |
| MNPR MONOPAR THERAPEUTICS | PURCHASE Chief Executive Officer | 24,474 | — | — | 152,900.8 | Dec 31, 2023 | Jan 3, 2024 ↗ | View → |
| MNPR MONOPAR THERAPEUTICS | SALE Chief Executive Officer | 24,474 | — | — | 229,009 | Dec 31, 2023 | Jan 3, 2024 ↗ | View → |
| MNPR MONOPAR THERAPEUTICS | SALE Chief Executive Officer | 8,469 | $0.34 | $2.9K | 144,431.8 | Dec 31, 2023 | Jan 3, 2024 ↗ | View → |
| MNPR MONOPAR THERAPEUTICS | SALE Chief Executive Officer | 24,474 | — | — | 253,483 | Sep 30, 2023 | Oct 3, 2023 ↗ | View → |
| MNPR MONOPAR THERAPEUTICS | SALE Chief Executive Officer | 7,172 | $0.62 | $4.4K | 128,426.8 | Sep 30, 2023 | Oct 3, 2023 ↗ | View → |
| MNPR MONOPAR THERAPEUTICS | PURCHASE Chief Executive Officer | 24,474 | — | — | 135,598.8 | Sep 30, 2023 | Oct 3, 2023 ↗ | View → |
| MNPR MONOPAR THERAPEUTICS | SALE Chief Executive Officer | 10,269 | $0.86 | $8.8K | 111,124.8 | Jun 30, 2023 | Jul 3, 2023 ↗ | View → |
| MNPR MONOPAR THERAPEUTICS | SALE Chief Executive Officer | 35,039 | — | — | 277,957 | Jun 30, 2023 | Jul 3, 2023 ↗ | View → |
| MNPR MONOPAR THERAPEUTICS | PURCHASE Chief Executive Officer | 35,039 | — | — | 121,393.8 | Jun 30, 2023 | Jul 3, 2023 ↗ | View → |
| MNPR MONOPAR THERAPEUTICS | PURCHASE Chief Executive Officer | 13,911 | — | — | 90,640.8 | Mar 31, 2023 | Apr 4, 2023 ↗ | View → |
| MNPR MONOPAR THERAPEUTICS | SALE Chief Executive Officer | 4,286 | $1.39 | $6.0K | 86,354.8 | Mar 31, 2023 | Apr 4, 2023 ↗ | View → |
| MNPR MONOPAR THERAPEUTICS | SALE Chief Executive Officer | 13,911 | — | — | 312,996 | Mar 31, 2023 | Apr 4, 2023 ↗ | View → |
| MNPR MONOPAR THERAPEUTICS | PURCHASEGRANT Stock grant | 169,012 | — | — | 326,907 | Feb 1, 2023 | Feb 3, 2023 ↗ | View → |
| MNPR MONOPAR THERAPEUTICS | PURCHASEGRANT Stock grant | 221,839 | — | — | 221,839 | Feb 1, 2023 | Feb 3, 2023 ↗ | View → |
| MNPR MONOPAR THERAPEUTICS | SALE Chief Executive Officer | 2,327 | $2.37 | $5.5K | 76,729.8 | Jan 1, 2023 | Jan 3, 2023 ↗ | View → |
| MNPR MONOPAR THERAPEUTICS | PURCHASE Chief Executive Officer | 6,723 | — | — | 79,056.8 | Jan 1, 2023 | Jan 3, 2023 ↗ | View → |
| MNPR MONOPAR THERAPEUTICS | SALE Chief Executive Officer | 6,723 | — | — | 6,724 | Jan 1, 2023 | Jan 3, 2023 ↗ | View → |
| MNPR MONOPAR THERAPEUTICS | SALE Chief Executive Officer | 13,912 | — | — | 151,171 | Dec 31, 2022 | Jan 3, 2023 ↗ | View → |
| MNPR MONOPAR THERAPEUTICS | SALE Chief Executive Officer | 4,814 | $2.37 | $11.4K | 72,333.8 | Dec 31, 2022 | Jan 3, 2023 ↗ | View → |
| MNPR MONOPAR THERAPEUTICS | PURCHASE Chief Executive Officer | 13,912 | — | — | 77,147.8 | Dec 31, 2022 | Jan 3, 2023 ↗ | View → |
| MNPR MONOPAR THERAPEUTICS | PURCHASE Chief Executive Officer | 13,911 | — | — | 67,312.8 | Sep 30, 2022 | Oct 3, 2022 ↗ | View → |
| MNPR MONOPAR THERAPEUTICS | SALE Chief Executive Officer | 4,077 | $1.52 | $6.2K | 63,235.8 | Sep 30, 2022 | Oct 3, 2022 ↗ | View → |
| MNPR MONOPAR THERAPEUTICS | SALE Chief Executive Officer | 13,911 | — | — | 178,530 | Sep 30, 2022 | Oct 3, 2022 ↗ | View → |
| MNPR MONOPAR THERAPEUTICS | PURCHASE Chief Executive Officer | 23,882 | — | — | 60,400.8 | Jun 30, 2022 | Jul 1, 2022 ↗ | View → |
| MNPR MONOPAR THERAPEUTICS | SALE Chief Executive Officer | 6,999 | $2.30 | $16.1K | 53,401.8 | Jun 30, 2022 | Jul 1, 2022 ↗ | View → |
| MNPR MONOPAR THERAPEUTICS | SALE Chief Executive Officer | 23,882 | — | — | 192,441 | Jun 30, 2022 | Jul 1, 2022 ↗ | View → |
| MNPR MONOPAR THERAPEUTICS | SALE Chief Executive Officer | 3,941 | — | — | 216,323 | Mar 31, 2022 | Apr 1, 2022 ↗ | View → |
| MNPR MONOPAR THERAPEUTICS | SALE Chief Executive Officer | 1,155 | $2.55 | $2.9K | 36,518.8 | Mar 31, 2022 | Apr 1, 2022 ↗ | View → |
| MNPR MONOPAR THERAPEUTICS | PURCHASE Chief Executive Officer | 3,941 | — | — | 37,673.8 | Mar 31, 2022 | Apr 1, 2022 ↗ | View → |
| MNPR MONOPAR THERAPEUTICS | PURCHASEGRANT Stock grant | 211,018 | — | — | 211,018 | Feb 2, 2022 | Feb 4, 2022 ↗ | View → |
| MNPR MONOPAR THERAPEUTICS | PURCHASEGRANT Stock grant | 159,522 | — | — | 220,264 | Feb 2, 2022 | Feb 4, 2022 ↗ | View → |
| MNPR MONOPAR THERAPEUTICS | SALE Chief Executive Officer | 2,327 | $3.21 | $7.5K | 33,732.8 | Jan 1, 2022 | Jan 4, 2022 ↗ | View → |
| MNPR MONOPAR THERAPEUTICS | SALE Chief Executive Officer | 6,724 | — | — | 13,447 | Jan 1, 2022 | Jan 4, 2022 ↗ | View → |
| MNPR MONOPAR THERAPEUTICS | PURCHASE Chief Executive Officer | 6,724 | — | — | 36,059.8 | Jan 1, 2022 | Jan 4, 2022 ↗ | View → |
| MNPR MONOPAR THERAPEUTICS | PURCHASE Chief Executive Officer | 3,941 | — | — | 30,699.8 | Dec 31, 2021 | Jan 4, 2022 ↗ | View → |
| MNPR MONOPAR THERAPEUTICS | SALE Chief Executive Officer | 3,941 | — | — | 47,295 | Dec 31, 2021 | Jan 4, 2022 ↗ | View → |
| MNPR MONOPAR THERAPEUTICS | SALE Chief Executive Officer | 1,364 | $3.21 | $4.4K | 29,335.8 | Dec 31, 2021 | Jan 4, 2022 ↗ | View → |
| MNPR MONOPAR THERAPEUTICS | PURCHASE Chief Executive Officer | 3,941 | — | — | 27,913.8 | Sep 30, 2021 | Oct 1, 2021 ↗ | View → |
| MNPR MONOPAR THERAPEUTICS | SALE Chief Executive Officer | 3,941 | — | — | 51,236 | Sep 30, 2021 | Oct 1, 2021 ↗ | View → |
| MNPR MONOPAR THERAPEUTICS | SALE Chief Executive Officer | 1,155 | $4.87 | $5.6K | 26,758.8 | Sep 30, 2021 | Oct 1, 2021 ↗ | View → |
| MNPR MONOPAR THERAPEUTICS | SALE Chief Executive Officer | 7,883 | — | — | 55,177 | Jun 30, 2021 | Jul 2, 2021 ↗ | View → |
| MNPR MONOPAR THERAPEUTICS | SALE Chief Executive Officer | 2,310 | $5.89 | $13.6K | 23,972.8 | Jun 30, 2021 | Jul 2, 2021 ↗ | View → |
| MNPR MONOPAR THERAPEUTICS | PURCHASE Chief Executive Officer | 7,883 | — | — | 26,282.8 | Jun 30, 2021 | Jul 2, 2021 ↗ | View → |
| MNPR MONOPAR THERAPEUTICS | SALE Chief Executive Officer | 24,224 | $14.09 | $341.3K | 224,976 | Feb 11, 2021 | Feb 16, 2021 ↗ | View → |
| MNPR MONOPAR THERAPEUTICS | SALE Chief Executive Officer | 16,384 | $16.44 | $269.4K | 178,596 | Feb 11, 2021 | Feb 16, 2021 ↗ | View → |
| MNPR MONOPAR THERAPEUTICS | SALE Chief Executive Officer | 42,467 | $13.30 | $564.8K | 249,200 | Feb 11, 2021 | Feb 16, 2021 ↗ | View → |
| MNPR MONOPAR THERAPEUTICS | SALE Chief Executive Officer | 11,929 | $16.90 | $201.6K | 166,667 | Feb 11, 2021 | Feb 16, 2021 ↗ | View → |
| MNPR MONOPAR THERAPEUTICS | SALE Chief Executive Officer | 29,996 | $15.12 | $453.5K | 194,980 | Feb 11, 2021 | Feb 16, 2021 ↗ | View → |
| MNPR MONOPAR THERAPEUTICS | PURCHASEGRANT Stock grant | 70,000 | — | — | 70,000 | Jan 26, 2021 | Jan 28, 2021 ↗ | View → |
| MNPR MONOPAR THERAPEUTICS | PURCHASEGRANT Stock grant | 63,060 | — | — | 83,231 | Jan 26, 2021 | Jan 28, 2021 ↗ | View → |
| MNPR MONOPAR THERAPEUTICS | SALE Chief Executive Officer | 2,327 | $6.12 | $14.2K | 18,399.8 | Jan 1, 2021 | Jan 5, 2021 ↗ | View → |
| MNPR MONOPAR THERAPEUTICS | PURCHASE Chief Executive Officer | 6,724 | — | — | 20,726.8 | Jan 1, 2021 | Jan 5, 2021 ↗ | View → |
| MNPR MONOPAR THERAPEUTICS | SALE Chief Executive Officer | 6,724 | — | — | 20,171 | Jan 1, 2021 | Jan 5, 2021 ↗ | View → |
| MNPR MONOPAR THERAPEUTICS | PURCHASEGRANT Stock grant | 111,753 | — | — | 111,753 | Jan 31, 2020 | Feb 20, 2020 ↗ | View → |
| MNPR MONOPAR THERAPEUTICS | PURCHASEGRANT Stock grant | 26,895 | — | — | 26,895 | Jan 31, 2020 | Feb 20, 2020 ↗ | View → |